ACI 36th Annual FDA Boot Camp
March 24, 2021

On March 24, Axinn partner Chad Landmon participated in a panel entitled, "Part 1 – Patents and Related IP Protections and Mechanisms" at ACI's virtual 36th Annual FDA Boot Camp.

This panel addressed several topics including, strategies for building patent protection for drugs and biologics and identifying the respective roles of the FDA and the PTO in the protection of drug and biological product trademarks. 

Click here for more information. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.